Related references
Note: Only part of the references are listed.Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Ian W. Flinn et al.
BLOOD (2014)
The Use and Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma Diagnosed Between 2004 and 2007 in the United States
Loretta J. Nastoupil et al.
CANCER (2014)
R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Brian K. Link et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
First-line treatment of indolent lymphoma: axing CHOP?
Caron A. Jacobson et al.
LANCET (2013)
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias J. Rummel et al.
LANCET (2013)
Pathobiology of chemotherapy-induced hair loss
Ralf Paus et al.
LANCET ONCOLOGY (2013)
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
Jonathan W. Friedberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II
Emily Cox et al.
VALUE IN HEALTH (2009)
Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part III
Michael L. Johnson et al.
VALUE IN HEALTH (2009)
Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I
Marc L. Berger et al.
VALUE IN HEALTH (2009)
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
Abdulwahab J. Al-Tourah et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients
Stefano Sacchi et al.
CANCER (2007)
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at the University of Texas M.D. Anderson Cancer Center
Q Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
W Hiddemann et al.
BLOOD (2005)
New treatment options have changed the survival of patients with follicular lymphoma
RI Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
P McLaughlin et al.
BLOOD (2005)
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma
R Marcus et al.
BLOOD (2005)
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
PL Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The meaning of quality of life in patients being treated for advanced breast cancer: A qualitative study
ML Luoma et al.
PSYCHO-ONCOLOGY (2004)
Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients
JO Armitage et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Psychological sequelae and alopecia among women with cancer
EL McGarvey et al.
CANCER PRACTICE (2001)
Share Paper
